Skip to content
Search

Latest Stories

Holland & Barrett continues 'every menopause matter' campaign to support minority women

In response to new research that revealed inequality in menopause support with 51 per cent of women from black, Asian and minority ethnic backgrounds, Holland & Barrett, the UK’s leading health and wellness retailer, has decided to continue its menopause campaign work to make “every menopause matter”.

A quarter of women (26 per cent) from minority ethnic communities say they find it difficult to access menopause support relevant to their specific backgrounds.


Alongside support from Olympian and menopause campaigner, Michelle Griffith Robinson and expert, Meera Bhogal, the retailer is launching several new initiatives to make its information and support on menopause more inclusive by offering more diverse and personalized advice and content, tailored to different needs.

Almost a third (31 per cent) believe being able to speak to a female healthcare professional of the same ethnicity as them would have made a difference to their menopause experience. Fifteen per cent go as far as saying that communicating in their native language would have made a positive difference.

Based on these findings, Holland and Barrett is the first retailer to launch a free, multi-language menopause online consultation service. The service will see trained H&B menopause advisors offering guidance and symptom support in multiple languages, starting with Hindi, Urdu, Gujarati and Punjabi.

Cross-cultural research shows a person’s race and cultural background may impact how a woman may feel about menopause, the severity of their symptoms, when the symptoms might start, and even how long they will last, for example – on average, black women start menopause two years earlier than their white European counterparts and will typically reach menopause aged 49.

A SWAN study found that for black women, symptoms such as hot flushes and night sweats are more often severe and last longer than those in white, European women. The symptoms in Asian women are different again.

Recognizing the need for a more tailored approach, all 4,000 H&B colleagues have also had extended training to help better advise on menopause symptoms and solutions.

Lina Chan, Director of Women’s Health at H&B, comments: “We have long supported women’s wellness and while a lot of work has taken place to break the taboo surrounding menopause, our customers have told us there’s still much more to do to represent every woman’s experience. That’s why we’ve worked with our colleagues, and leading campaigners such as Menopause Mandate and Wellbeing of Women to look at simple ways we can help all women to be heard and supported, both through H&B and out in the communities we serve. We know there is more to do to make the menopause conversation truly inclusive of all experiences, and this is our next step on that journey.”

Menopause expert, Meera Bhogal, says: “In the South Asian community, women’s health isn’t talked about generally, so when I started experiencing perimenopausal symptoms at 40, I had no clue what was happening to me. I wish I had been equipped with the right information, which is why I really welcome the steps H&B is taking. I really want to help remove the stigma of the menopause and open-up conversations and help women from all communities be able to access the advice and support they need.”

As part of H&B’s Every Menopause Matters campaign, customers will find menopause content online in different languages, and in a pilot, its ad campaign will be translated in Hindi to reach and support a wider community of women for whom language may be a barrier.

The retailer has also partnered with leading women’s health charity, Wellbeing of Women, to launch ‘The Women’s Health Community Fund’ which will provide resources to individuals and groups in under-served communities with a specific focus on those from lower income families, ethnically diverse communities, those with disabilities and LGBTQ+, to raise awareness and provide information on menopause in the way that best reaches and serves the needs of their community.

Janet Lindsay, CEO, Wellbeing of Women, said: “We are excited to be working with Holland & Barrett to launch the Women’s Health Community Fund. By providing grants to people from under-served groups, we hope it will give them the resources needed to help improve awareness, education and support on the menopause in their communities.

“There are stark inequalities for women and people when accessing menopause information and care which are generally not designed to meet the particular needs of Black, Asian or other ethnic minority groups, as well as those from economically disadvantaged backgrounds or with disabilities and LGBTQ+. We look forward to collaborating with communities throughout the UK to help ensure no woman or person is left behind when it comes to the menopause.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less